📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. (2016)

First Author: Courtney DG

Attributed to: Developing targeted therapeutics for keratinizing skin disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/gt.2015.82

PubMed Identifier: 26289666

Publication URI: http://europepmc.org/abstract/MED/26289666

Type: Journal Article/Review

Volume: 23

Parent Publication: Gene therapy

Issue: 1

ISSN: 0969-7128